To: sean who wrote (1172 ) 5/27/1999 2:06:00 PM From: sean Read Replies (1) | Respond to of 1286
NBMX News $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ Thursday May 27, 1:30 pm Eastern Time Company Press Release National Boston Medical Inc. Announces It Has No Plans to Reverse Split Their Stock in Spite of Rumors TAUNTON, Mass.--(BUSINESS WIRE)--May 27, 1999--According to ''chat room'' rumors on the Internet, false information is spreading concerning a split in NBMX stock. ''This is absolutely not true!'' according to Daniel Hoyng of National Boston Medical Inc. (OTC BB:NBMX - news) Hoyng stated that: ''National Boston Medical Inc.'s revenues continued to increase during the month of May. The company has shipped orders for this period exceeding $905,000 in revenues combined sales for their Bontempi and Backstroke divisions.'' Furthermore, the company is ready to file its FORM 10 to make the company a fully reporting company the first half of June 1999. Visit the company web site at www.nbmedical.com for current information on the company's progress. Also, Bontempi Surgical instruments, which are exclusively distributed by National Boston Medical Inc. will soon be available through a new E-commerce site, which will debut early June. The company desires to build a results oriented reputation and is moving in a positive, profitable way with highly profitable results. At this time the company is confident that these profitable results will grow stronger each month and will eliminate emotional trading decisions. National Boston Medical Inc. distributes, manufactures and designs infection-reducing medical and dental instruments and personal care products engineered to enhance public health and hygiene. Their products include Safeshield(tm) antimicrobial skin protectant cream, the Bontempi line of surgical and dental instruments, and the Backstroke Back Massager. This material was prepared by Joyce Research Group Inc. (''JRG''), for the company discussed herein, based upon information supplied by the client or other sources believed to be reliable. The company's actual results could differ materially from those described in the forward-looking statement discussed in this press release. This material is for information purposes and should not be construed as an offer or solicitation of an offer to buy or sell the securities. JRG, its affiliates, and/or its officers, directors and employees may from time to time have a position in these securities. JRG has received compensation for preparation of this press release. -------------------------------------------------------------------------------- Contact: Joyce Research Group, Inc., Boca Raton L. DeBeach, 561/361-9277 or Fax 561/361-9217